Phase II study of Rituximab in Patients with Systemic Lupus Erythematosus
Not Applicable
- Conditions
- Systemic lupus erythematosus
- Registration Number
- JPRN-UMIN000000762
- Lead Sponsor
- Zenyaku Kogyo Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Not provided
Exclusion Criteria
1)Proteinuria>1.0g/24hr 2)APS complication 3)Pregnant women or lactating mothers 4)Positive HIV, HCV, HBs, HBc etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy evaluation
- Secondary Outcome Measures
Name Time Method